News
![PolyPid_logo](https://pharmaphorum.com/wp-content/uploads/2022/09/PolyPid_logo.jpg)
Data dive could give PolyPid antibiotic a lifeline
Shares in PolyPid have been under pressure after the Israeli biotech reported its antibiotic for surgical site infections failed a phase 3 trial, although there may still be a way forward f